Evogene Ltd.
TASE:EVGN 株式レポート
Evogene マネジメント 主要情報 CEO給与比率 97.3% CEO在任期間 19.9yrs CEOの所有権 n/a 経営陣の平均在職期間 2.6yrs 取締役会の平均在任期間 5.8yrs
経営陣の近況
Evogene Ltd. Announces Executive Changes Sep 17
Evogene Ltd., Annual General Meeting, Jun 06, 2024 May 01
Casterra Ag Ltd., a subsidiary of Evogene Ltd Announces Executive Changes, Effective January 1, 2024 Dec 19
Evogene Ltd., Annual General Meeting, May 11, 2023 May 06
Evogene Ltd., Annual General Meeting, Sep 08, 2022 Aug 04
Eyal Ronen Joins as Executive Vice President of Business Development of Evogene Ltd., Effective as of June 12, 2022 Jun 02
すべての更新を表示
Evogene Ltd. to Report Q3, 2024 Results on Nov 21, 2024 Nov 07
Evogene Ltd. Announces Executive Changes Sep 17
Evogene Ltd. to Report Q2, 2024 Results on Aug 22, 2024 Aug 12
Evogene Ltd. to Report Q1, 2024 Results on May 23, 2024 May 11
Evogene Ltd., Annual General Meeting, Jun 06, 2024 May 01 Evogene Ltd. has filed a Follow-on Equity Offering in the amount of $7.3 million. Mar 30
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification Mar 21
Full year 2023 earnings released: US$0.52 loss per share (vs US$0.65 loss in FY 2022) Mar 07
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate Mar 05
Evogene Ltd. to Report Q4, 2023 Results on Mar 07, 2024 Feb 27
Casterra Ag Ltd., a subsidiary of Evogene Ltd Announces Executive Changes, Effective January 1, 2024 Dec 19
New major risk - Share price stability Dec 06
New minor risk - Shareholder dilution Nov 20
Third quarter 2023 earnings released: US$0.081 loss per share (vs US$0.16 loss in 3Q 2022) Nov 18
Evogene Ltd. to Report Q3, 2023 Results on Nov 15, 2023 Nov 03
Will Evogene (TLV:EVGN) Spend Its Cash Wisely? Oct 09
Second quarter 2023 earnings released: US$0.17 loss per share (vs US$0.21 loss in 2Q 2022) Aug 18
Evogene Ltd. to Report Q2, 2023 Results on Aug 17, 2023 Aug 01
Evogene Ltd 's ChemPass AI Tech-Engine is Introduces with New Breakthrough Machine Learning Technology for Target-Protein Discovery Jul 26
Biomica Ltd. Reports Interim Positive Results from Pre-Clinical Studies in its IBS Program Jul 22
Will Evogene (TLV:EVGN) Spend Its Cash Wisely? Jun 26
New minor risk - Share price stability Jun 21
Evogene Ltd., Annual General Meeting, May 11, 2023 May 06
Evogene Ltd. to Report Q1, 2023 Results on May 18, 2023 May 05
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate Mar 13
Full year 2022 earnings released: US$0.65 loss per share (vs US$0.69 loss in FY 2021) Mar 11
Third quarter 2022 earnings released: US$0.16 loss per share (vs US$0.19 loss in 3Q 2021) Nov 21
Evogene Ltd. to Report Q3, 2022 Results on Nov 17, 2022 Nov 08
Here's Why We're Watching Evogene's (TLV:EVGN) Cash Burn Situation Oct 07
Second quarter 2022 earnings released: US$0.21 loss per share (vs US$0.15 loss in 2Q 2021) Sep 02
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule Aug 27
Evogene Ltd., Annual General Meeting, Sep 08, 2022 Aug 04
Evogene Ltd. to Report Q2, 2022 Results on Aug 31, 2022 Aug 03
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate Jun 16
Eyal Ronen Joins as Executive Vice President of Business Development of Evogene Ltd., Effective as of June 12, 2022 Jun 02
First quarter 2022 earnings released: US$0.20 loss per share (vs US$0.17 loss in 1Q 2021) May 28
Evogene Ltd. to Report Q1, 2022 Results on May 26, 2022 May 12
High number of new directors Mar 29
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Mar 11
Will Evogene (TLV:EVGN) Spend Its Cash Wisely? Mar 02
Evogene Ltd. to Report Q4, 2021 Results on Mar 10, 2022 Feb 16
High number of new directors Feb 04
Evogene Ltd. Announces Executive Changes Feb 03
Chief Executive Officer of AgPlenus Ltd. Douglas Eisner has left the company Dec 01
Third quarter 2021 earnings released: US$0.19 loss per share (vs US$0.18 loss in 3Q 2020) Nov 18
High number of new and inexperienced directors Nov 02
Second quarter 2021 earnings released: US$0.15 loss per share (vs US$0.17 loss in 2Q 2020) Aug 12
First quarter 2021 earnings released: US$0.17 loss per share (vs US$0.24 loss in 1Q 2020) May 28
Here's Why We're Not Too Worried About Evogene's (TLV:EVGN) Cash Burn Situation May 28
Full year 2020 earnings released: US$0.83 loss per share (vs US$0.70 loss in FY 2019) Apr 04
Evogene Ltd. to Report Q4, 2020 Results on Mar 03, 2021 Feb 18
New 90-day high: ₪25.00 Feb 04
Companies Like Evogene (TLV:EVGN) Are In A Position To Invest In Growth Jan 21
New 90-day high: ₪19.10 Jan 14
New 90-day high: ₪14.94 Dec 24
What Can We Make Of Evogene's (TLV:EVGN) CEO Compensation? Nov 30
Third quarter 2020 earnings released: US$0.18 loss per share Nov 19
Evogene Ltd. to Report Q3, 2020 Results on Nov 18, 2020 Nov 03
First half earnings released Sep 17
New 90-day high - ₪9.46 Sep 16
New 90-day high - ₪5.63 Aug 27
New 90-day high - ₪4.17 Aug 10
First half earnings released Aug 06
Evogene Ltd. to Report Q2, 2020 Results on Aug 05, 2020 Jul 17
CEO報酬分析 Evogene の収益と比較して、Ofer Haviv の報酬はどのように変化したか？ 日付 総報酬 給与 会社業績 Jun 30 2024 n/a n/a -US$20m
Mar 31 2024 n/a n/a -US$21m
Dec 31 2023 US$401k US$390k -US$24m
Sep 30 2023 n/a n/a -US$20m
Jun 30 2023 n/a n/a -US$23m
Mar 31 2023 n/a n/a -US$25m
Dec 31 2022 US$464k US$415k -US$27m
Sep 30 2022 n/a n/a -US$31m
Jun 30 2022 n/a n/a -US$32m
Mar 31 2022 n/a n/a -US$29m
Dec 31 2021 US$530k US$420k -US$28m
Sep 30 2021 n/a n/a -US$29m
Jun 30 2021 n/a n/a -US$26m
Mar 31 2021 n/a n/a -US$24m
Dec 31 2020 US$592k US$367k -US$23m
Sep 30 2020 n/a n/a -US$21m
Jun 30 2020 n/a n/a -US$21m
Mar 31 2020 n/a n/a -US$21m
Dec 31 2019 US$538k US$366k -US$18m
Sep 30 2019 n/a n/a -US$18m
Jun 30 2019 n/a n/a -US$18m
Mar 31 2019 n/a n/a -US$19m
Dec 31 2018 US$517k US$324k -US$21m
Sep 30 2018 n/a n/a -US$21m
Jun 30 2018 n/a n/a -US$21m
Mar 31 2018 n/a n/a -US$21m
Dec 31 2017 US$649k US$359k -US$21m
報酬と市場: Oferの 総報酬 ($USD 401.00K ) は、 IL市場 ($USD 425.15K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Oferの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者 Mr. Ofer Haviv, CPA, served as Interim Chief Executive Officer of Lavie Bio Ltd. since January 2023. He has been Chief Executive Officer and President of Evogene Limited since December 2004 and served as i ... Show more
リーダーシップ・チーム 名称 ポジション 在職期間 報酬 所有権 CEO & President 19.9yrs US$401.00k データなし Chief Executive Officer of AgPlenus Ltd 2.9yrs US$456.00k データなし Chief Executive Officer of Biomica Ltd 6.8yrs US$339.00k 0% ₪ 0 Chief Executive Officer of Lavie Bio Ltd. 1.6yrs US$606.00k データなし Chief Financial Officer 2.6yrs データなし 0% ₪ 0 Head of Investor Relations 1.4yrs データなし データなし Vice President of Corporate Development 2.8yrs US$304.00k 0% ₪ 0 Vice President of Human Resources 2.8yrs データなし データなし Executive Vice President of Business Development 2.4yrs データなし 0% ₪ 0 Chief Executive Officer of Casterra Ag Ltd. less than a year データなし データなし Chief Executive Officer of Ag Plenus Ltd. less than a year データなし データなし Vice President of Commercial of Lavie Bio Ltd. no data データなし データなし
もっと見る
経験豊富な経営陣: EVGNの経営陣は 経験豊富 であると考えられます ( 2.6年の平均在職年数)。
取締役 名称 ポジション 在職期間 報酬 所有権 Independent Director 3yrs データなし 0% ₪ 0 Independent Director 2yrs データなし 0% ₪ 0 Independent Director 19.5yrs データなし 1.56% ₪ 574.0k Independent Chairperson of the Board 8.3yrs データなし 0% ₪ 0 Independent Director 6yrs データなし 0% ₪ 0 Independent Director 5.8yrs データなし 0% ₪ 0 Scientific Advisor 2.8yrs データなし データなし
もっと見る
経験豊富なボード: EVGNの 取締役会 は 経験豊富 であると考えられます ( 5.8年の平均在任期間)。
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
